Valid Property-Enhanced Contrastive Learning for Targeted Optimization & Resampling for Novel Drug Design

Efficiently steering generative models toward pharmacologically relevant regions of chemical space remains a major obstacle in molecular drug discovery under low-data regimes. We present VECTOR+: Valid-property-Enhanced Contrastive Learning for Targeted Optimization and Resampling, a framework that couples property-guided representation learning with controllable molecule generation. VECTOR+ applies to both regression and classification tasks and enables interpretable, data-efficient exploration of functional chemical space. We evaluate on two datasets: a curated PD-L1 inhibitor set (296 compounds with experimental IC50 values) and a receptor kinase inhibitor set (2,056 molecules by binding mode). Despite limited training data, VECTOR+ generates novel, synthetically tractable candidates. Against PD-L1 (PDB 5J89), 100 of 8,374 generated molecules surpass a docking threshold of -15.0 kcal/mol, with the best scoring -17.6 kcal/mol compared to the top reference inhibitor (-15.4 kcal/mol). The best-performing molecules retain the conserved biphenyl pharmacophore while introducing novel motifs. Molecular dynamics (250 ns) confirm binding stability (ligand RMSD < 2.5 angstroms). VECTOR+ generalizes to kinase inhibitors, producing compounds with stronger docking scores than established drugs such as brigatinib and sorafenib. Benchmarking against JT-VAE and MolGPT across docking, novelty, uniqueness, and Tanimoto similarity highlights the superior performance of our method. These results position our work as a robust, extensible approach for property-conditioned molecular design in low-data settings, bridging contrastive learning and generative modeling for reproducible, AI-accelerated discovery.